Clover Health Investments Net Income
| CLOV Stock | USD 2.04 0.07 3.32% |
As of the 5th of February, Clover Health shows the Mean Deviation of 2.41, risk adjusted performance of (0.08), and Standard Deviation of 3.19. Clover Health Investments technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Clover Health Investments variance and skewness to decide if Clover Health Investments is priced correctly, providing market reflects its regular price of 2.04 per share. Please also double-check Clover Health Investments jensen alpha, which is currently at (0.46) to validate the company can sustain itself at a future point.
Clover Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Clover Health's valuation are provided below:Clover Health Investments does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. What growth prospects exist in Health Care Providers & Services sector? Can Clover capture new markets? Factors like these will boost the valuation of Clover Health. Projected growth potential of Clover fundamentally drives upward valuation adjustments. Valuation analysis balances hard financial data with qualitative growth assessments. While each Clover Health valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Investors evaluate Clover Health Investments using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Clover Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. External factors like market trends, sector rotation, and investor psychology can cause Clover Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Clover Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clover Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Clover Health's market price signifies the transaction level at which participants voluntarily complete trades.
Clover Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clover Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clover Health.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Clover Health on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Clover Health Investments or generate 0.0% return on investment in Clover Health over 90 days. Clover Health is related to or competes with Procept Biorobotics, Twist Bioscience, Quidel, National HealthCare, Qilian International, Guardian Pharmacy, and Lifestance Health. Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States More
Clover Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clover Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clover Health Investments upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 17.39 | |||
| Value At Risk | (4.86) | |||
| Potential Upside | 5.26 |
Clover Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clover Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clover Health's standard deviation. In reality, there are many statistical measures that can use Clover Health historical prices to predict the future Clover Health's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.24) |
Clover Health February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.23) | |||
| Mean Deviation | 2.41 | |||
| Coefficient Of Variation | (816.09) | |||
| Standard Deviation | 3.19 | |||
| Variance | 10.17 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.24) | |||
| Maximum Drawdown | 17.39 | |||
| Value At Risk | (4.86) | |||
| Potential Upside | 5.26 | |||
| Skewness | 0.8277 | |||
| Kurtosis | 1.78 |
Clover Health Investments Backtested Returns
Clover Health Investments secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Clover Health Investments exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clover Health's Standard Deviation of 3.19, mean deviation of 2.41, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.66, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Clover Health will likely underperform. At this point, Clover Health Investments has a negative expected return of -0.39%. Please make sure to confirm Clover Health's information ratio, skewness, as well as the relationship between the Skewness and day typical price , to decide if Clover Health Investments performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.28 |
Weak reverse predictability
Clover Health Investments has weak reverse predictability. Overlapping area represents the amount of predictability between Clover Health time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clover Health Investments price movement. The serial correlation of -0.28 indicates that nearly 28.0% of current Clover Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.28 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Clover Health Investments reported net income of (43.01 Million). This is 112.6% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 107.53% higher than that of the company.
Clover Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clover Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clover Health could also be used in its relative valuation, which is a method of valuing Clover Health by comparing valuation metrics of similar companies.Clover Health is currently under evaluation in net income category among its peers.
Clover Fundamentals
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.0594 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 807.31 M | ||||
| Shares Outstanding | 424.3 M | ||||
| Shares Owned By Insiders | 3.33 % | ||||
| Shares Owned By Institutions | 32.18 % | ||||
| Number Of Shares Shorted | 40.19 M | ||||
| Price To Book | 3.26 X | ||||
| Price To Sales | 0.61 X | ||||
| Revenue | 1.37 B | ||||
| Gross Profit | 375.61 M | ||||
| EBITDA | (44.94 M) | ||||
| Net Income | (43.01 M) | ||||
| Cash And Equivalents | 711.78 M | ||||
| Cash Per Share | 1.49 X | ||||
| Total Debt | 239.6 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 0.66 X | ||||
| Cash Flow From Operations | 34.84 M | ||||
| Short Ratio | 8.13 X | ||||
| Earnings Per Share | (0.11) X | ||||
| Price To Earnings To Growth | (0.08) X | ||||
| Target Price | 3.23 | ||||
| Number Of Employees | 570 | ||||
| Beta | 2.15 | ||||
| Market Capitalization | 1.09 B | ||||
| Total Asset | 580.74 M | ||||
| Retained Earnings | (2.2 B) | ||||
| Working Capital | 129.61 M | ||||
| Net Asset | 580.74 M |
About Clover Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clover Health Investments's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clover Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clover Health Investments based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clover Stock Analysis
When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.